AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 39709140 — intervention group
Group type: EXPERIMENTAL
Intervention: HEC88473
Number of subjects: 60
Study 39709189 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block and popliteal plexus block
Number of subjects: 66
Study 39709189 — intervention group
Group type: COMPARATOR
Intervention: Continuous femoral nerve block alone
Number of subjects: 66
Study 39709368 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary team assessment and individualized treatment (MDT)
Number of subjects: 220
Study 39709368 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and commitment therapy (ACT)
Number of subjects: 220
Study 39709368 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 220
Study 39709372 — intervention group
Group type: EXPERIMENTAL
Intervention: PULSAR with HyperArc© software, 11 Gray fraction of radiation every two weeks for a total of five fractions (total dose of 55 Gy)
Number of subjects: 43
Study 39709372 — intervention group
Group type: EXPERIMENTAL
Intervention: PULSAR with HyperArc© software
Number of subjects: 43
Study 39709402 — intervention group
Group type: EXPERIMENTAL
Intervention: L-PRF loaded with Metronidazole
Number of subjects: 24
Study 39709402 — intervention group
Group type: COMPARATOR
Intervention: L-PRF alone
Number of subjects: 24
Study 39709419 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild sedation and analgesia
Number of subjects: 96
Study 39709419 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl (control)
Number of subjects: 96
Study 39709459 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD Coach mobile app
Number of subjects: 39
Study 39709459 — intervention group
Group type: COMPARATOR
Intervention: Attention-control tasks
Number of subjects: 39
Study 39709458 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive Parents-Coping Kids (SPARCK) parent training intervention
Number of subjects: 0
Study 39709458 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive Parents-Coping Kids (SPARCK)
Number of subjects: 0
Study 39709468 — intervention group
Group type: EXPERIMENTAL
Intervention: AB-free kava, 3 times per day for 4 weeks
Number of subjects: 76
Study 39709468 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 3 times per day for 4 weeks
Number of subjects: 76
Study 39709751 — intervention group
Group type: COMPARATOR
Intervention: Magnitude of variability analysis using principal component scores
Number of subjects: 0
Study 39709751 — intervention group
Group type: COMPARATOR
Intervention: Structure of variability analysis using principal component scores
Number of subjects: 0
Study 39709786 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse practitioner-led collaborative health care model (12-week program)
Number of subjects: 100
Study 39709786 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing guidance (Control group)
Number of subjects: 100
Study 39709786 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse practitioner-led collaborative health care model
Number of subjects: 100
Study 39709979 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfluthrin-based spatial repellent
Number of subjects: 3072
Study 39709979 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 3072
Study 39710167 — intervention group
Group type: EXPERIMENTAL
Intervention: ceftazidime-avibactam + metronidazole for 5-14 days
Number of subjects: 60
Study 39710167 — intervention group
Group type: EXPERIMENTAL
Intervention: ceftazidime-avibactam + metronidazole
Number of subjects: 60
Study 39710171 — intervention group
Group type: EXPERIMENTAL
Intervention: synbiotic mix (COMP group)
Number of subjects: 41
Study 39710171 — intervention group
Group type: COMPARATOR
Intervention: synbiotic mix enriched with pigmented corn extract (EXP group)
Number of subjects: 41
Study 39710337 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health (mHealth) intervention promoting appropriate gestational weight gain (GWG)
Number of subjects: 0
Study 39710337 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study 39710352 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravascular lithotripsy (IVL)
Number of subjects: 666
Study 39710352 — intervention group
Group type: COMPARATOR
Intervention: Other calcium-modifying techniques (modified or super high-pressure balloon and atheroablative devices)
Number of subjects: 666
Study 39710508 — intervention group
Group type: EXPERIMENTAL
Intervention: Dostarlimab monotherapy (Arm A)
Number of subjects: 198
Study 39710508 — intervention group
Group type: EXPERIMENTAL
Intervention: Dostarlimab + bevacizumab (Arm B)
Number of subjects: 198
Study 39710508 — intervention group
Group type: COMPARATOR
Intervention: Investigator's choice of chemotherapy (Arm C)
Number of subjects: 198
Study 39710693 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone (20 mg/day on days 1-5, 10 mg/day on days 6-10)
Number of subjects: 234
Study 39710693 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose dexamethasone (6 mg/day, days 1-10)
Number of subjects: 234
Study 39710693 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone
Number of subjects: 234
Study 39710693 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose dexamethasone
Number of subjects: 234
Study 39710697 — intervention group
Group type: EXPERIMENTAL
Intervention: ICG-HSA complex
Number of subjects: 0
Study 39710697 — intervention group
Group type: COMPARATOR
Intervention: Guideline-recommended ICG administration scheme
Number of subjects: 0
Study 39710733 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 123
Study 39711127 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-4-0 (liberal group)
Number of subjects: 200
Study 39711127 — intervention group
Group type: COMPARATOR
Intervention: 6-4-2 (standard group)
Number of subjects: 200
Study 39711191 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction Program
Number of subjects: 0
Study 39711191 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 39711194 — intervention group
Group type: EXPERIMENTAL
Intervention: Propolis-based protocol for oral health in palliative care
Number of subjects: 0
Study 39711194 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 39711285 — intervention group
Group type: EXPERIMENTAL
Intervention: Early PBO (< 46 years)
Number of subjects: 231
Study 39711425 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin administration with negative pressure wound therapy (NPWT)
Number of subjects: 10
Study 39711430 — intervention group
Group type: EXPERIMENTAL
Intervention: Anlotinib plus PD-1 inhibitor
Number of subjects: 29
Study 39711557 — intervention group
Group type: EXPERIMENTAL
Intervention: Medications for opioid use disorder (MOUD)
Number of subjects: 60
Study 39711557 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to treatment initiation and retention
Number of subjects: 60
Study 39711557 — intervention group
Group type: EXPERIMENTAL
Intervention: Organizational characteristics
Number of subjects: 60
Study 39711557 — intervention group
Group type: EXPERIMENTAL
Intervention: Community characteristics
Number of subjects: 60
Study 39711557 — intervention group
Group type: EXPERIMENTAL
Intervention: Policy changes
Number of subjects: 60
Study 39711557 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-level efforts
Number of subjects: 60
Study 39711560 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention for acute myocardial infarction diagnosis and treatment
Number of subjects: 0
Study 39711702 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram with grief-informed clinical management
Number of subjects: 333
Study 39711702 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram with prolonged grief disorder therapy (PGDT)
Number of subjects: 333
Study 39711702 — intervention group
Group type: COMPARATOR
Intervention: Pill placebo with PGDT
Number of subjects: 333
Study 39711702 — intervention group
Group type: COMPARATOR
Intervention: Pill placebo with clinical management
Number of subjects: 333
Study 39711790 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical rotation chair (MRC) diagnostics
Number of subjects: 215
Study 39711790 — intervention group
Group type: COMPARATOR
Intervention: Traditional manual BPPV diagnostics (MD)
Number of subjects: 215
Study 39711792 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial cocktail therapy with argatroban, dexamethasone, and edaravone administered for 30 minutes into the culprit artery after sufficient recanalization.
Number of subjects: 30
Study 39711792 — intervention group
Group type: COMPARATOR
Intervention: Control group (retrospective data of patients who met inclusion/exclusion criteria).
Number of subjects: 30
Study 39712455 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrotinib combined with fulvestrant
Number of subjects: 46
Study 39712511 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyadic Mindfulness Self-Compassion intervention (six weekly sessions)
Number of subjects: 0
Study 39713041 — intervention group
Group type: EXPERIMENTAL
Intervention: ANG1005 (600 mg/m2)
Number of subjects: 73
Study 39713088 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth behavioral weight loss program
Number of subjects: 21
Study 39713266 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 0
Study 39713266 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study 39713278 — intervention group
Group type: EXPERIMENTAL
Intervention: lehfilcon A (TOTAL30 for Astigmatism) contact lenses worn from 8:00 AM until 12:00 AM each day for 1 month
Number of subjects: 47
Study 39713795 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical intervention to improve adherence to PPI; 122 out of 178 non-adherent patients received the intervention.
Number of subjects: 351
Study 39713935 — intervention group
Group type: EXPERIMENTAL
Intervention: Domagrozumab (an antibody-targeting myostatin)
Number of subjects: 0
Study 39714033 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth physical activity counseling intervention
Number of subjects: 24
Study 39714090 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended Reality (ER) program for 14 weeks including active video gaming and mindfulness practices.
Number of subjects: 16
Study 39714090 — intervention group
Group type: COMPARATOR
Intervention: Usual care in the hospital followed by an 8-week home ER program after a waiting period.
Number of subjects: 16
Study 39714546 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib 150 mg capsules twice daily
Number of subjects: 5717
Study 39714620 — intervention group
Group type: EXPERIMENTAL
Intervention: Coblation tonsillectomy
Number of subjects: 8854
Study 39714637 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Group (LIG)
Number of subjects: 101
Study 39714637 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Group (MIG)
Number of subjects: 101
Study 39714786 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent RPM ratings of MADRS
Number of subjects: 58
Study 39714786 — intervention group
Group type: COMPARATOR
Intervention: Site ratings of MADRS
Number of subjects: 58
Study 39714786 — intervention group
Group type: EXPERIMENTAL
Intervention: MADRS rating pairs
Number of subjects: 58
Study 39714786 — intervention group
Group type: EXPERIMENTAL
Intervention: Rater training and monitoring
Number of subjects: 58
Study 39714843 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-Family Partnership (NFP) home visiting program
Number of subjects: 4877
Study 39714843 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 4877
Study 39714889 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior gastropexy
Number of subjects: 240
Study 39714889 — intervention group
Group type: COMPARATOR
Intervention: No anterior gastropexy
Number of subjects: 240
Study 39714936 — intervention group
Group type: COMPARATOR
Intervention: Hybrid closed-loop insulin delivery
Number of subjects: 82
Study 39714936 — intervention group
Group type: COMPARATOR
Intervention: Predictive low-glucose suspend insulin delivery
Number of subjects: 82
Study 39714936 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-augmented pump insulin delivery
Number of subjects: 82
Study 39715103 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-limited trial (TLT) initiated in the ED
Number of subjects: 40
Study 39715234 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital clinical decision support algorithm (CDSA) enhanced by point-of-care tests, training, and mentorship
Number of subjects: 450
Study 39715234 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 450
Study 39715234 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital clinical decision support algorithm (CDSA)
Number of subjects: 450
Study 39715423 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI) + mentoring
Number of subjects: 81
Study 39715423 — intervention group
Group type: COMPARATOR
Intervention: Mentoring-alone
Number of subjects: 81
Study 39715425 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive Parenting (RP) intervention
Number of subjects: 212
Study 39715425 — intervention group
Group type: COMPARATOR
Intervention: Safety control condition
Number of subjects: 212
Study 39715424 — intervention group
Group type: EXPERIMENTAL
Intervention: Friend-based motivational intervention (FMI)
Number of subjects: 102
Study 39715424 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 102
Study 39715475 — intervention group
Group type: EXPERIMENTAL
Intervention: Atogepant 60 mg once daily (QD)
Number of subjects: 1193
Study 39715475 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1193
Study 39715568 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic drink containing Bifidus ActiRegularis (5x10^8) strain, administered once a day for 15 consecutive days.
Number of subjects: 36
Study 39715568 — intervention group
Group type: COMPARATOR
Intervention: Non-pharmaceutical standard care treatment (Control).
Number of subjects: 36
Study 39715568 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic drink (I).
Number of subjects: 36
Study 39715569 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor imagery ability (assessed using Kinesthetic and Visual Imagery Questionnaire-20)
Number of subjects: 60
Study 39715569 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental chronometry task scores
Number of subjects: 60
Study 39715569 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor imagery ability
Number of subjects: 60
Study 39715573 — intervention group
Group type: EXPERIMENTAL
Intervention: VDOT (Video Directly Observed Therapy)
Number of subjects: 142
Study 39715573 — intervention group
Group type: COMPARATOR
Intervention: UCDOT (Usual Care Directly Observed Therapy)
Number of subjects: 142
Study 39715573 — intervention group
Group type: EXPERIMENTAL
Intervention: VDOT
Number of subjects: 142
Study 39715573 — intervention group
Group type: COMPARATOR
Intervention: UCDOT
Number of subjects: 142
Study 39715748 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterologous Ad26.ZEBOV/MVA-BN®-Filo prime-boost
Number of subjects: 60
Study 39715748 — intervention group
Group type: EXPERIMENTAL
Intervention: MVA-BN®-Filo boost at 1 year
Number of subjects: 60
Study 39715748 — intervention group
Group type: COMPARATOR
Intervention: Homologous prime-boost
Number of subjects: 60
Study 39715755 — intervention group
Group type: EXPERIMENTAL
Intervention: Toripalimab plus chemotherapy
Number of subjects: 0
Study 39715755 — intervention group
Group type: COMPARATOR
Intervention: Control group (chemotherapy alone)
Number of subjects: 0
Study 39715848 — intervention group
Group type: EXPERIMENTAL
Intervention: Malignant lesions
Number of subjects: 154
Study 39715848 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 154
Study 39715848 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography
Number of subjects: 154
Study 39715945 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified ICU rooms with dynamic lighting system
Number of subjects: 64
Study 39715945 — intervention group
Group type: COMPARATOR
Intervention: Standard ICU rooms
Number of subjects: 64
Study 39715945 — intervention group
Group type: EXPERIMENTAL
Intervention: Both modified and standard ICU rooms (influence of light)
Number of subjects: 64
Study 39715945 — intervention group
Group type: EXPERIMENTAL
Intervention: Both modified and standard ICU rooms (interaction over time)
Number of subjects: 64
Study 39716084 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal calprotectin (FC) levels in the Obese + NAFLD group
Number of subjects: 31
Study 39716084 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal calprotectin (FC) levels in the Obese group
Number of subjects: 31
Study 39716084 — intervention group
Group type: COMPARATOR
Intervention: Fecal calprotectin (FC) levels in the Healthy control group
Number of subjects: 31
Study 39716084 — intervention group
Group type: COMPARATOR
Intervention: FC positivity rates in the Healthy control group
Number of subjects: 31
Study 39716084 — intervention group
Group type: EXPERIMENTAL
Intervention: FC positivity rates in the Obese group
Number of subjects: 31
Study 39716084 — intervention group
Group type: EXPERIMENTAL
Intervention: FC positivity rates in the Obese + NAFLD group
Number of subjects: 31
Study 39716103 — intervention group
Group type: EXPERIMENTAL
Intervention: QuestOnco application
Number of subjects: 110
Study 39716103 — intervention group
Group type: COMPARATOR
Intervention: PRO-CTCAE
Number of subjects: 110
Study 39716103 — intervention group
Group type: COMPARATOR
Intervention: Medical records
Number of subjects: 110
Study 39716127 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief data set (EQ-5D-5L and additional generic PROMs)
Number of subjects: 2904
Study 39716127 — intervention group
Group type: COMPARATOR
Intervention: Longer data set (including Patient-Specific Functional Scale and 29-item PROMIS Profile instruments)
Number of subjects: 2904
Study 39716202 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention targeting emotional wellbeing and resilience
Number of subjects: 400
Study 39716202 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Health Record (EHR) skills training
Number of subjects: 400
Study 39716202 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance improvement training
Number of subjects: 400
Study 39716202 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 400
Study 39716203 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD)
Number of subjects: 104
Study 39716203 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD) + Physical activity (PA)
Number of subjects: 104
Study 39716203 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 104
Study 39716323 — intervention group
Group type: EXPERIMENTAL
Intervention: PAL-222 (adipose tissue-derived mesenchymal stem cell sheets)
Number of subjects: 0
Study 39716442 — intervention group
Group type: EXPERIMENTAL
Intervention: Acalabrutinib treatment (n=23, NP group)
Number of subjects: 41
Study 39716442 — intervention group
Group type: EXPERIMENTAL
Intervention: Acalabrutinib treatment (n=18, PD group)
Number of subjects: 41
Study 39716442 — intervention group
Group type: EXPERIMENTAL
Intervention: High surface expression of CD49d and CD79b prior to acalabrutinib therapy
Number of subjects: 41
Study 39716442 — intervention group
Group type: EXPERIMENTAL
Intervention: RNA-seq and flow cytometry profiling
Number of subjects: 41
Study 39716523 — intervention group
Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 0
Study 39716659 — intervention group
Group type: EXPERIMENTAL
Intervention: 25(OH)D
Number of subjects: 361
Study 39716875 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-754 gene therapy
Number of subjects: 4
Study 39716881 — intervention group
Group type: EXPERIMENTAL
Intervention: Cs-131 prostate brachytherapy (PB)
Number of subjects: 138
Study 39716986 — intervention group
Group type: EXPERIMENTAL
Intervention: eLym™ System
Number of subjects: 50
Study 39717077 — intervention group
Group type: EXPERIMENTAL
Intervention: Acti-Pair programme (motivational support from a peer, construction of a personalised project, support from health and adapted PA professionals)
Number of subjects: 0
Study 39717077 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (advice and recommendations for PA during consultations)
Number of subjects: 0
Study 39717073 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention delivered by videoconference, 2 classes/week for 12 weeks
Number of subjects: 0
Study 39717227 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological-based cord clamping (PBCC)
Number of subjects: 669
Study 39717227 — intervention group
Group type: COMPARATOR
Intervention: Time-based delayed cord clamping (TBCC)
Number of subjects: 669
Study 39717281 — intervention group
Group type: EXPERIMENTAL
Intervention: Derived DVT score with 2 objective variables
Number of subjects: 1312
Study 39717281 — intervention group
Group type: EXPERIMENTAL
Intervention: Derived DVT score with D-dimer cutoff of <0.5 µg/mL
Number of subjects: 1312
Study 39717281 — intervention group
Group type: COMPARATOR
Intervention: Wells score
Number of subjects: 1312
Study 39717452 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet Rich Plasma (PRP) injection
Number of subjects: 50
Study 39717452 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid (CS) injection
Number of subjects: 50
Study 39717499 — intervention group
Group type: EXPERIMENTAL
Intervention: AHA HeartSaver® course
Number of subjects: 221
Study 39717499 — intervention group
Group type: EXPERIMENTAL
Intervention: JIT training video
Number of subjects: 221
Study 39717499 — intervention group
Group type: COMPARATOR
Intervention: Control (no training)
Number of subjects: 221
Study 39717511 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal medical device
Number of subjects: 27
Study 39717517 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea therapy (daily administration, escalated to maximum tolerated dose over 36 months)
Number of subjects: 270
Study 39717518 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia end-of-life care planning intervention with adaptations based on community engagement via a Community Advisory Board (CAB)
Number of subjects: 0
Study 39717518 — intervention group
Group type: EXPERIMENTAL
Intervention: Framework for Reporting Adaptations and Modifications to Evidence-based Interventions (FRAME) model
Number of subjects: 0